Richland One is now accepting applications for 2026–2027 magnet choice programs, with options in STEM, health sciences, ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...

Foods high in protein and fiber are better at holding off hunger—that can include eggs, fatty fish, oatmeal, and more.

As of Monday, December 08, Virco Mfg. Corporation’s VIRC share price has dipped by 12.85%, which has investors questioning if this is right time to buy.

Overall survival was twice as long for people treated with Columvi in combination with GemOx versus MabThera/Rituxan plus ...

Basel, 8 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data highlighting the potential of Lunsumio® (mosunetuzumab) in earlier treatment lines for people living with different ...

SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...

A Milton Keynes charity has granted £2.8m of funding for scientists working on treatments for low-grade brain tumours.

The American Heart Association hosted its second STEM Goes Red event to introduce eighth grade girls to careers in STEM.

Duquesne University officials say a new, $68 million health sciences facility will locate clinical services, consolidate ...

SAN ANTONIO -- Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) ...